STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD

Turner D, Ricciuto A, Lewis A, D'Amico F, Dhaliwal J, Griffiths AM, Bettenworth D, Sandborn WJ, Sands BE, Reinisch W, Schölmerich J, Bemelman W, Danese S, Mary JY, Rubin D, Colombel JF, Peyrin-Biroulet L, Dotan I, Abreu MT, Dignass A; International Organization for the Study of IBD

Published Feb 2021, in the Gastroenterology

Safety of ustekinumab or vedolizumab in pregnant inflammatory bowel disease patients: a multicentre cohort study

Wils P, Seksik P, Stefanescu C, Nancey S, Allez M, Pineton de Chambrun G, Altwegg R, Gilletta C, Vuitton L, Viennot S, Serrero M, Fumery M, Savoye G, Collins M, Goutorbe F, Brixi H, Bouguen G, Tavernier N, Boualit M, Amiot A, Abitbol V, Laharie D, Pariente B; PREGNANCY-GETAID study group

Published Feb 2021, in the Alimentary pharmacology & therapeutics

Randomised clinical trial: high-dose oral thiamine versus placebo for chronic fatigue in patients with quiescent inflammatory bowel disease

Bager P, Hvas CL, Rud CL, Dahlerup JF.

Published Jan 2021, in the Alimentary pharmacology & therapeutics

Point-of-Care Ultrasound in Inflammatory Bowel Disease

Allocca M, Furfaro F, Fiorino G, Peyrin-Biroulet L, Danese S.

Published Jan 2021, in the Journal of Crohn's & colitis.

Faecal Biomarkers in Inflammatory Bowel Diseases: Calprotectin Versus Lipocalin-2-a Comparative Study

Zollner A, Schmiderer A, Reider SJ, Oberhuber G, Pfister A, Texler B, Watschinger C, Koch R, Effenberger M, Raine T, Tilg H, Moschen AR

Published Jan 2021, in the Journal of Crohn's & colitis.

Pathophysiology of Inflammatory Bowel Diseases

John T Chang

Published Dec 2020, in the New England journal of medicine

Diet in Treatment of Inflammatory Bowel Diseases

Sasson AN, Ananthakrishnan AN, Raman M

Published Mar 2021, in the Clinical gastroenterology and hepatology.

COVID-19 and IBD drugs: should we change anything at the moment?

Lees CW, Irving PM, Beaugerie L

Published Nov 2020, in the Gut

Effect of IBD medications on COVID-19 outcomes: results from an international registry

Ungaro RC, Brenner EJ, Gearry RB, Kaplan GG, Kissous-Hunt M, Lewis JD, Ng SC, Rahier JF, Reinisch W, Steinwurz F, Underwood FE, Zhang X, Colombel JF, Kappelman MD.

Published Oct 2020, in the Gut.

Thiopurine monotherapy is effective in ulcerative colitis but significantly less so in Crohn's disease: long-term outcomes for 11 928 patients in the UK inflammatory bowel disease bioresource

Stournaras E, Qian W, Pappas A, Hong YY, Shawky R; UK IBD BioResource Investigators, Raine T, Parkes M; UK IBD Bioresource Investigators

Published Oct 2020, in the Gut.